Dermochelys coriacea isolate rDerCor1 chromosome 21, rDerCor1.pri.v4, whole genome shotgun sequence.
Dermochelys coriacea (leatherback sea turtle)
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Archelosauria; Testudinata; Testudines; Cryptodira; Durocryptodira; Americhelydia; Chelonioidea; Dermochelyidae; Dermochelys.
REFSEQ INFORMATION: The reference sequence is identical to\nCM019955.3.\nAssembly name: rDerCor1.pri.v4\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the G10K on 2021/08/25. The\noriginal whole-genome shotgun project has the accession\nWSPL00000000.4.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: G10K\nAssembly Date :: 24-MAY-2021\nAssembly Method :: FALCON DNANexus v. 1.9.0; FALCON-Unzip\n DNANexus v. 1.0.6; purge_dups v. v1;\n scaff10x v. 4.1.0; Bionano Solve DLS v.\n 3.2.1; Salsa HiC v. 2.2.2; Arrow\n smrtanalysis Pacbio polishing & gap\n filling v. 6.0.0.47841; longranger align\n v. 2.2.2; freebayes Illumina polishing v.\n 1.3.1; gEVAL manual curation v.\n 2021-05-24; VGP assembly pipeline\n individual v. 1.6\nAssembly Name :: rDerCor1.pri.v4\nDiploid :: Principal Pseudohaplotype\nGenome Representation :: Full\nExpected Final Version :: No\nGenome Coverage :: 63.68x\nSequencing Technology :: PacBio Sequel I CLR; llumina NovaSeq;\n Arima Genomics Hi-C; Bionano Genomics DLS\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Dermochelys coriacea Annotation\n Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
uncharacterized LOC119846452, transcript variant X3
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC119846452, transcript variant X2
uncharacterized LOC119846452, transcript variant X1
uncharacterized LOC122457160, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
uncharacterized LOC122457160, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 63 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
zinc finger protein 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
zinc finger protein 2-like, transcript variant X3
zinc finger protein 2-like, transcript variant X2
zinc finger protein 2-like, transcript variant X1
nerve growth factor, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
nerve growth factor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 65 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
nerve growth factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nerve growth factor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 58 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
thyroid stimulating hormone subunit beta
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC122457142, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC122457142, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC122457142, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized protein LOC122457142 isoform X1
uncharacterized protein LOC122457142 isoform X2
bile acid receptor-like, transcript variant X3
bile acid receptor-like, transcript variant X1
bile acid receptor-like, transcript variant X2
suppressor of IKBKE 1, transcript variant X1
suppressor of IKBKE 1, transcript variant X5
suppressor of IKBKE 1, transcript variant X4
suppressor of IKBKE 1, transcript variant X2
suppressor of IKBKE 1, transcript variant X8
suppressor of IKBKE 1, transcript variant X6
suppressor of IKBKE 1, transcript variant X10
suppressor of IKBKE 1, transcript variant X12
suppressor of IKBKE 1, transcript variant X11
suppressor of IKBKE 1, transcript variant X7
suppressor of IKBKE 1, transcript variant X3
suppressor of IKBKE 1, transcript variant X9
cold shock domain containing E1, transcript variant X1
cold shock domain containing E1, transcript variant X3
cold shock domain containing E1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 44 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
cold shock domain containing E1, transcript variant X2
cold shock domain containing E1, transcript variant X4
cold shock domain containing E1, transcript variant X5
cold shock domain containing E1, transcript variant X6
cold shock domain-containing protein E1 isoform X1
cold shock domain-containing protein E1 isoform X2
cold shock domain-containing protein E1 isoform X3
NRAS proto-oncogene, GTPase, transcript variant X3
NRAS proto-oncogene, GTPase, transcript variant X1
NRAS proto-oncogene, GTPase, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: DENN domain-containing protein 2C
tripartite motif containing 33, transcript variant X1
tripartite motif containing 33, transcript variant X2
E3 ubiquitin-protein ligase TRIM33 isoform X1
E3 ubiquitin-protein ligase TRIM33 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 69 long SRA reads, 11 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
homeodomain interacting protein kinase 1, transcript variant X2
homeodomain interacting protein kinase 1, transcript variant X3
homeodomain interacting protein kinase 1, transcript variant X1
homeodomain-interacting protein kinase 1 isoform X2
homeodomain-interacting protein kinase 1 isoform X1
transcription initiation factor TFIID subunit 4-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 98% coverage of the annotated genomic feature by RNAseq alignments
DNA cross-link repair 1B, transcript variant X6
DNA cross-link repair 1B, transcript variant X7
DNA cross-link repair 1B, transcript variant X4
DNA cross-link repair 1B, transcript variant X1
DNA cross-link repair 1B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
DNA cross-link repair 1B, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
DNA cross-link repair 1B, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DNA cross-link repair 1B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
DNA cross-link repair 1B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 long SRA reads, 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
adaptor related protein complex 4 subunit beta 1, transcript variant X1
adaptor related protein complex 4 subunit beta 1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: bcl-2-like protein 15
uncharacterized LOC119846418, transcript variant X2
uncharacterized LOC119846418, transcript variant X3
uncharacterized LOC119846418, transcript variant X1
uncharacterized protein LOC119846418 isoform X1
uncharacterized protein LOC119846418 isoform X2
protein tyrosine phosphatase non-receptor type 22, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 22, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 22, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 22, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 44 samples with support for all annotated introns
tyrosine-protein phosphatase non-receptor type 22 isoform X1
tyrosine-protein phosphatase non-receptor type 22 isoform X2
tyrosine-protein phosphatase non-receptor type 22 isoform X4
tyrosine-protein phosphatase non-receptor type 22 isoform X3
protein tyrosine phosphatase non-receptor type 22, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 22, transcript variant X6
tyrosine-protein phosphatase non-receptor type 22 isoform X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: lysine-specific demethylase 9
putative homeodomain transcription factor 1, transcript variant X2
putative homeodomain transcription factor 1, transcript variant X3
putative homeodomain transcription factor 1, transcript variant X4
putative homeodomain transcription factor 1, transcript variant X1
putative homeodomain transcription factor 1, transcript variant X5
putative homeodomain transcription factor 1, transcript variant X6
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X3
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X2
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X1
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X3
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X2
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X1
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
membrane associated guanylate kinase, WW and PDZ domain containing 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X5
membrane-associated guanylate kinase, WW and PDZ domain-containing protein 3 isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 90% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeats and immunoglobulin like domains 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: leucine-rich repeats and immunoglobulin-like domains protein 2
uncharacterized LOC119846197, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC119846197, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
solute carrier family 16 member 1, transcript variant X4
solute carrier family 16 member 1, transcript variant X3
solute carrier family 16 member 1, transcript variant X5
solute carrier family 16 member 1, transcript variant X1
solute carrier family 16 member 1, transcript variant X2
uncharacterized LOC122457143, transcript variant X1
uncharacterized LOC122457143, transcript variant X2
TAFA chemokine like family member 3, transcript variant X2
TAFA chemokine like family member 3, transcript variant X1
TAFA chemokine like family member 3, transcript variant X3
chemokine-like protein TAFA-3 isoform X1
chemokine-like protein TAFA-3 isoform X2
protein phosphatase, Mg2+/Mn2+ dependent 1J
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 62 long SRA reads, 1 Protein, and 89% coverage of the annotated genomic feature by RNAseq alignments, including 58 samples with support for all annotated introns
capping actin protein of muscle Z-line subunit alpha 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: suppressor of tumorigenicity 7 protein-like
uncharacterized LOC119846503, transcript variant X2
uncharacterized LOC119846503, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, and 91% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
CTTNBP2 N-terminal like, transcript variant X1
CTTNBP2 N-terminal like, transcript variant X2
CTTNBP2 N-terminal like, transcript variant X4
CTTNBP2 N-terminal like, transcript variant X3
CTTNBP2 N-terminal-like protein isoform X1
CTTNBP2 N-terminal-like protein isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC119846504, transcript variant X1
uncharacterized LOC119846504, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily D member 3, transcript variant X2
potassium voltage-gated channel subfamily D member 3, transcript variant X3
potassium voltage-gated channel subfamily D member 3, transcript variant X1
potassium voltage-gated channel subfamily D member 3 isoform X1
potassium voltage-gated channel subfamily D member 3 isoform X2
DEAD-box helicase 20, transcript variant X1
DEAD-box helicase 20, transcript variant X2
probable ATP-dependent RNA helicase DDX20 isoform X1
probable ATP-dependent RNA helicase DDX20 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
RAP1A, member of RAS oncogene family, transcript variant X4
RAP1A, member of RAS oncogene family, transcript variant X1
RAP1A, member of RAS oncogene family, transcript variant X3
RAP1A, member of RAS oncogene family, transcript variant X5
RAP1A, member of RAS oncogene family, transcript variant X7
RAP1A, member of RAS oncogene family, transcript variant X2
RAP1A, member of RAS oncogene family, transcript variant X6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: adenosine receptor A3
ATP synthase peripheral stalk-membrane subunit b
ATP synthase F(0) complex subunit B1, mitochondrial
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
LOW QUALITY PROTEIN: methylosome protein 50
uncharacterized protein C6orf132 homolog
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 49% coverage of the annotated genomic feature by RNAseq alignments
interferon regulatory factor 6, transcript variant X3
interferon regulatory factor 6, transcript variant X1
interferon regulatory factor 6, transcript variant X2
TRAF3 interacting protein 3, transcript variant X4
TRAF3 interacting protein 3, transcript variant X8
TRAF3 interacting protein 3, transcript variant X3
TRAF3 interacting protein 3, transcript variant X1
TRAF3 interacting protein 3, transcript variant X9
TRAF3 interacting protein 3, transcript variant X2
TRAF3 interacting protein 3, transcript variant X11
TRAF3 interacting protein 3, transcript variant X5
TRAF3 interacting protein 3, transcript variant X10
TRAF3 interacting protein 3, transcript variant X6
TRAF3 interacting protein 3, transcript variant X7
TRAF3-interacting JNK-activating modulator isoform X4
TRAF3-interacting JNK-activating modulator isoform X3
TRAF3-interacting JNK-activating modulator isoform X1
TRAF3-interacting JNK-activating modulator isoform X2
TRAF3-interacting JNK-activating modulator isoform X7
TRAF3-interacting JNK-activating modulator isoform X6
TRAF3-interacting JNK-activating modulator isoform X5
TRAF3-interacting JNK-activating modulator isoform X8
laminin subunit beta 3, transcript variant X1
hydroxysteroid 11-beta dehydrogenase 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X2
hydroxysteroid 11-beta dehydrogenase 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
corticosteroid 11-beta-dehydrogenase isozyme 1 isoform X1
laminin subunit beta 3, transcript variant X6
laminin subunit beta 3, transcript variant X4
laminin subunit beta 3, transcript variant X5
laminin subunit beta 3, transcript variant X2
laminin subunit beta 3, transcript variant X3
calcium/calmodulin dependent protein kinase IG, transcript variant X2
calcium/calmodulin dependent protein kinase IG, transcript variant X1
calcium/calmodulin-dependent protein kinase type 1G
olfactory receptor class A-like protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: olfactory receptor class A-like protein 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC119846431, transcript variant X2
uncharacterized LOC119846431, transcript variant X1
uncharacterized LOC119846441, transcript variant X2
uncharacterized LOC119846441, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC119846441, transcript variant X1
uncharacterized LOC122457147, transcript variant X3
uncharacterized LOC122457147, transcript variant X4
uncharacterized LOC122457147, transcript variant X1
uncharacterized LOC122457147, transcript variant X5
uncharacterized LOC122457147, transcript variant X2
hematopoietic progenitor cell antigen CD34 isoform X1
hematopoietic progenitor cell antigen CD34 isoform X2
hematopoietic progenitor cell antigen CD34 isoform X3
uncharacterized LOC119846507, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC119846507, transcript variant X1
uncharacterized LOC119846507, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
C4b-binding protein alpha chain-like, transcript variant X13
C4b-binding protein alpha chain-like, transcript variant X6
C4b-binding protein alpha chain-like, transcript variant X3
C4b-binding protein alpha chain-like, transcript variant X19
C4b-binding protein alpha chain-like, transcript variant X15
C4b-binding protein alpha chain-like, transcript variant X9
C4b-binding protein alpha chain-like, transcript variant X16
C4b-binding protein alpha chain-like, transcript variant X20
C4b-binding protein alpha chain-like, transcript variant X10
C4b-binding protein alpha chain-like, transcript variant X5
C4b-binding protein alpha chain-like, transcript variant X12
C4b-binding protein alpha chain-like, transcript variant X2
C4b-binding protein alpha chain-like, transcript variant X11
C4b-binding protein alpha chain-like, transcript variant X4
C4b-binding protein alpha chain-like, transcript variant X1
C4b-binding protein alpha chain-like, transcript variant X18
C4b-binding protein alpha chain-like, transcript variant X14
C4b-binding protein alpha chain-like, transcript variant X7
C4b-binding protein alpha chain-like, transcript variant X8
C4b-binding protein alpha chain-like, transcript variant X17
C4b-binding protein alpha chain-like isoform X13
C4b-binding protein alpha chain-like isoform X6
complement component receptor 1-like protein isoform X3
C4b-binding protein alpha chain-like isoform X19
membrane cofactor protein-like isoform X15
membrane cofactor protein-like isoform X9
C4b-binding protein alpha chain-like isoform X20
membrane cofactor protein-like isoform X16
membrane cofactor protein-like isoform X10
C4b-binding protein alpha chain-like isoform X5
membrane cofactor protein-like isoform X12
complement component receptor 1-like protein isoform X2
membrane cofactor protein-like isoform X11
complement component receptor 1-like protein isoform X4
complement component receptor 1-like protein isoform X1
C4b-binding protein alpha chain-like isoform X18
membrane cofactor protein-like isoform X14
membrane cofactor protein-like isoform X7
complement component receptor 1-like protein isoform X8
complement receptor type 2-like isoform X17
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 long SRA reads, 19 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: complement receptor type 1-like
complement decay-accelerating factor-like
complement component receptor 1-like protein
uncharacterized LOC119846329, transcript variant X2
uncharacterized LOC119846329, transcript variant X1
sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1-like
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X8
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 34 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 46 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 45 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X9
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X5
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X3
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X2
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X1
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X7
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X6
6-phosphofructo-2-kinase/fructose-2, 6-biphosphatase 2, transcript variant X4
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X7
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X2
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X1
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X6
6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase 2 isoform X4
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: ubiquitin thioesterase OTU1
chromosome 21 C1orf116 homolog, transcript variant X4
chromosome 21 C1orf116 homolog, transcript variant X1
chromosome 21 C1orf116 homolog, transcript variant X5
chromosome 21 C1orf116 homolog, transcript variant X2
chromosome 21 C1orf116 homolog, transcript variant X3
specifically androgen-regulated gene protein isoform X1
specifically androgen-regulated gene protein isoform X2
Fc fragment of IgM receptor, transcript variant X2
Fc fragment of IgM receptor, transcript variant X3
Fc fragment of IgM receptor, transcript variant X1
fas apoptotic inhibitory molecule 3 isoform X1
fas apoptotic inhibitory molecule 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 19 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X2
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X4
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X3
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X1
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X6
dual specificity tyrosine phosphorylation regulated kinase 3, transcript variant X5
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X2
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X3
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X1
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X4
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X5
dual specificity tyrosine-phosphorylation-regulated kinase 3 isoform X6
eukaryotic translation initiation factor 2D, transcript variant X3
eukaryotic translation initiation factor 2D, transcript variant X1
eukaryotic translation initiation factor 2D, transcript variant X2
eukaryotic translation initiation factor 2D isoform X1
eukaryotic translation initiation factor 2D isoform X3
eukaryotic translation initiation factor 2D isoform X2
eukaryotic translation initiation factor 2D, transcript variant X4
eukaryotic translation initiation factor 2D isoform X4
Ras association domain family member 5, transcript variant X2
Ras association domain family member 5, transcript variant X1
ras association domain-containing protein 5 isoform X1
ras association domain-containing protein 5 isoform X2
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X3
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X1
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X5
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X2
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X1
inhibitor of nuclear factor kappa B kinase subunit epsilon, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
inhibitor of nuclear factor kappa-B kinase subunit epsilon isoform X2
SLIT-ROBO Rho GTPase activating protein 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: SLIT-ROBO Rho GTPase-activating protein 2
family with sequence similarity 72 member A
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 28 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
regulator of hemoglobinization and erythroid cell expansion, transcript variant X9
regulator of hemoglobinization and erythroid cell expansion, transcript variant X7
regulator of hemoglobinization and erythroid cell expansion, transcript variant X6
regulator of hemoglobinization and erythroid cell expansion, transcript variant X5
regulator of hemoglobinization and erythroid cell expansion, transcript variant X4
regulator of hemoglobinization and erythroid cell expansion, transcript variant X2
regulator of hemoglobinization and erythroid cell expansion, transcript variant X3
regulator of hemoglobinization and erythroid cell expansion, transcript variant X1
regulator of hemoglobinization and erythroid cell expansion, transcript variant X8
regulator of hemoglobinization and erythroid cell expansion protein isoform X1
regulator of hemoglobinization and erythroid cell expansion protein isoform X2
regulator of hemoglobinization and erythroid cell expansion protein isoform X3
RAB7B, member RAS oncogene family, transcript variant X1
RAB7B, member RAS oncogene family, transcript variant X2
RAB7B, member RAS oncogene family, transcript variant X3
N-fatty-acyl-amino acid synthase/hydrolase PM20D1
solute carrier family 41 member 1, transcript variant X2
solute carrier family 41 member 1, transcript variant X1
solute carrier family 41 member 1, transcript variant X3
solute carrier family 41 member 1 isoform X2
solute carrier family 41 member 1 isoform X1
solute carrier family 41 member 1 isoform X3
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X1
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X1
nuclear casein kinase and cyclin dependent kinase substrate 1, transcript variant X2
nuclear ubiquitous casein and cyclin-dependent kinase substrate 1 isoform X2
solute carrier family 45 member 3, transcript variant X4
solute carrier family 45 member 3, transcript variant X2
solute carrier family 45 member 3, transcript variant X1
solute carrier family 45 member 3, transcript variant X3
solute carrier family 45 member 3, transcript variant X5
ETS transcription factor ELK4, transcript variant X4
ETS transcription factor ELK4, transcript variant X8
ETS transcription factor ELK4, transcript variant X2
ETS transcription factor ELK4, transcript variant X5
ETS transcription factor ELK4, transcript variant X7
ETS transcription factor ELK4, transcript variant X6
ETS transcription factor ELK4, transcript variant X3
ETS transcription factor ELK4, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
ETS transcription factor ELK4, transcript variant X1
major facilitator superfamily domain containing 4A
major facilitator superfamily domain-containing protein 4A
cyclin dependent kinase 18, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 44 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cyclin dependent kinase 18, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC119846284, transcript variant X1
uncharacterized LOC119846284, transcript variant X2
LEM domain containing 1, transcript variant X1
LEM domain containing 1, transcript variant X4
LEM domain containing 1, transcript variant X3
LEM domain containing 1, transcript variant X5
LEM domain containing 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA tryptophan (anticodon CCA); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
LEM domain-containing protein 1 isoform X1
LEM domain-containing protein 1 isoform X3
LEM domain-containing protein 1 isoform X2
LEM domain-containing protein 1 isoform X4
kelch domain containing 8A, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
kelch domain containing 8A, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
transmembrane and coiled-coil domain family 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transmembrane and coiled-coil domains protein 2
uncharacterized LOC119846360, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC119846360, transcript variant X1
dual serine/threonine and tyrosine protein kinase
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X8
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X1
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X2
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X9
retinoblastoma-binding protein 5 isoform X1
retinoblastoma-binding protein 5 isoform X2
retinoblastoma-binding protein 5 isoform X4
retinoblastoma-binding protein 5 isoform X5
RB binding protein 5, histone lysine methyltransferase complex subunit, transcript variant X7
retinoblastoma-binding protein 5 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 75 long SRA reads, 26 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
MDM4 regulator of p53, transcript variant X1
MDM4 regulator of p53, transcript variant X2
transfer RNA lysine (anticodon UUU); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X2
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X1
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta isoform X1
phosphatidylinositol-4-phosphate 3-kinase catalytic subunit type 2 beta, transcript variant X3
phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta isoform X2
protein phosphatase 1 regulatory subunit 15B
pleckstrin homology domain containing A6, transcript variant X1
pleckstrin homology domain containing A6, transcript variant X5
pleckstrin homology domain-containing family A member 6 isoform X1
pleckstrin homology domain-containing family A member 6 isoform X4
pleckstrin homology domain containing A6, transcript variant X4
pleckstrin homology domain containing A6, transcript variant X3
pleckstrin homology domain containing A6, transcript variant X2
pleckstrin homology domain containing A6, transcript variant X7
pleckstrin homology domain-containing family A member 6 isoform X2
pleckstrin homology domain-containing family A member 6 isoform X6
pleckstrin homology domain-containing family A member 6 isoform X3
pleckstrin homology domain containing A6, transcript variant X6
pleckstrin homology domain-containing family A member 6 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
ethanolamine kinase 2, transcript variant X4
ethanolamine kinase 2, transcript variant X2
ethanolamine kinase 2, transcript variant X3
ethanolamine kinase 2, transcript variant X1
ethanolamine kinase 2, transcript variant X5
SRY-box transcription factor 13, transcript variant X17
SRY-box transcription factor 13, transcript variant X10
SRY-box transcription factor 13, transcript variant X4
SRY-box transcription factor 13, transcript variant X9
SRY-box transcription factor 13, transcript variant X15
SRY-box transcription factor 13, transcript variant X3
SRY-box transcription factor 13, transcript variant X13
SRY-box transcription factor 13, transcript variant X2
SRY-box transcription factor 13, transcript variant X16
SRY-box transcription factor 13, transcript variant X14
SRY-box transcription factor 13, transcript variant X12
SRY-box transcription factor 13, transcript variant X6
SRY-box transcription factor 13, transcript variant X1
SRY-box transcription factor 13, transcript variant X8
SRY-box transcription factor 13, transcript variant X5
SRY-box transcription factor 13, transcript variant X7
SRY-box transcription factor 13, transcript variant X11
small nuclear ribonucleoprotein polypeptide E
zinc finger CCCH-type containing 11A, transcript variant X4
zinc finger CCCH-type containing 11A, transcript variant X6
zinc finger CCCH-type containing 11A, transcript variant X5
zinc finger CCCH-type containing 11A, transcript variant X2
zinc finger CCCH-type containing 11A, transcript variant X7
zinc finger CCCH-type containing 11A, transcript variant X3
zinc finger CCCH-type containing 11A, transcript variant X9
zinc finger CCCH-type containing 11A, transcript variant X8
zinc finger CCCH domain-containing protein 11A isoform X5
zinc finger CCCH domain-containing protein 11A isoform X4
zinc finger CCCH domain-containing protein 11A isoform X2
zinc finger CCCH domain-containing protein 11A isoform X3
zinc finger CCCH domain-containing protein 11A isoform X1
zinc finger CCCH-type containing 11A, transcript variant X1
ATPase plasma membrane Ca2+ transporting 4, transcript variant X6
ATPase plasma membrane Ca2+ transporting 4, transcript variant X4
ATPase plasma membrane Ca2+ transporting 4, transcript variant X5
ATPase plasma membrane Ca2+ transporting 4, transcript variant X10
ATPase plasma membrane Ca2+ transporting 4, transcript variant X2
ATPase plasma membrane Ca2+ transporting 4, transcript variant X8
ATPase plasma membrane Ca2+ transporting 4, transcript variant X11
ATPase plasma membrane Ca2+ transporting 4, transcript variant X1
ATPase plasma membrane Ca2+ transporting 4, transcript variant X3
ATPase plasma membrane Ca2+ transporting 4, transcript variant X9
ATPase plasma membrane Ca2+ transporting 4, transcript variant X7
plasma membrane calcium-transporting ATPase 4 isoform X1
plasma membrane calcium-transporting ATPase 4 isoform X3
plasma membrane calcium-transporting ATPase 4 isoform X2
proline and arginine rich end leucine rich repeat protein
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
chitotriosidase-1-like, transcript variant X1
chitotriosidase-1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 long SRA reads, 75 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 60 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
TATA-box binding protein associated factor 8, transcript variant X1
TATA-box binding protein associated factor 8, transcript variant X4
TATA-box binding protein associated factor 8, transcript variant X3
TATA-box binding protein associated factor 8, transcript variant X2
transcription initiation factor TFIID subunit 8 isoform X1
transcription initiation factor TFIID subunit 8 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 long SRA reads, 27 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 62 samples with support for all annotated introns
mediator complex subunit 20, transcript variant X1
mediator complex subunit 20, transcript variant X2
mediator complex subunit 20, transcript variant X3
mediator of RNA polymerase II transcription subunit 20 isoform X1
mediator of RNA polymerase II transcription subunit 20 isoform X2
mediator complex subunit 20, transcript variant X4
mediator of RNA polymerase II transcription subunit 20 isoform X3
ubiquitin specific peptidase 49, transcript variant X12
ubiquitin specific peptidase 49, transcript variant X3
ubiquitin specific peptidase 49, transcript variant X5
ubiquitin specific peptidase 49, transcript variant X13
ubiquitin specific peptidase 49, transcript variant X14
ubiquitin specific peptidase 49, transcript variant X6
ubiquitin specific peptidase 49, transcript variant X9
ubiquitin specific peptidase 49, transcript variant X2
ubiquitin specific peptidase 49, transcript variant X4
ubiquitin specific peptidase 49, transcript variant X11
ubiquitin specific peptidase 49, transcript variant X7
ubiquitin specific peptidase 49, transcript variant X8
ubiquitin specific peptidase 49, transcript variant X1
ubiquitin specific peptidase 49, transcript variant X10
ubiquitin carboxyl-terminal hydrolase 49 isoform X1
ubiquitin carboxyl-terminal hydrolase 49 isoform X2
translocase of outer mitochondrial membrane 6, transcript variant X1
translocase of outer mitochondrial membrane 6, transcript variant X2
translocase of outer mitochondrial membrane 6, transcript variant X4
translocase of outer mitochondrial membrane 6, transcript variant X3
mitochondrial import receptor subunit TOM6 homolog
periphilin-1-like, transcript variant X2
periphilin-1-like, transcript variant X9
periphilin-1-like, transcript variant X1
periphilin-1-like, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
periphilin-1-like, transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
periphilin-1-like, transcript variant X7
periphilin-1-like, transcript variant X17
periphilin-1-like, transcript variant X8
periphilin-1-like, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 22 samples with support for all annotated introns
periphilin-1-like, transcript variant X15
periphilin-1-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
periphilin-1-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
periphilin-1-like, transcript variant X11
periphilin-1-like, transcript variant X4
uncharacterized protein LOC119846466 isoform X1
uncharacterized protein LOC119846466 isoform X2
uncharacterized protein LOC119846466 isoform X4
uncharacterized protein LOC119846466 isoform X8
uncharacterized protein LOC119846466 isoform X5
uncharacterized protein LOC119846466 isoform X7
periphilin-1-like, transcript variant X18
periphilin-1-like, transcript variant X6
periphilin-1-like, transcript variant X13
uncharacterized protein LOC119846466 isoform X3
uncharacterized protein LOC119846466 isoform X11
periphilin-1-like, transcript variant X12
uncharacterized protein LOC119846466 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 22 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
fibroblast growth factor receptor substrate 3-like isoform X1
fibroblast growth factor receptor substrate 3-like isoform X2
fibroblast growth factor receptor substrate 3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 45 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 35 Proteins, and 48% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 43 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
transcription factor EB, transcript variant X5
transcription factor EB, transcript variant X4
transcription factor EB, transcript variant X1
transcription factor EB, transcript variant X3
transcription factor EB, transcript variant X2
uncharacterized LOC122457131, transcript variant X2
uncharacterized LOC122457131, transcript variant X1
MyoD family inhibitor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 7 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
MyoD family inhibitor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 78% coverage of the annotated genomic feature by RNAseq alignments
triggering receptor expressed on myeloid cells 2-like, transcript variant X2
triggering receptor expressed on myeloid cells 2-like, transcript variant X1
triggering receptor expressed on myeloid cells 2-like isoform X1
triggering receptor expressed on myeloid cells 2-like isoform X2
CMRF35-like molecule 5, transcript variant X2
CMRF35-like molecule 5, transcript variant X1
CMRF35-like molecule 5, transcript variant X4
CMRF35-like molecule 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized protein LOC119846389 isoform X1
trem-like transcript 1 protein isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 62% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: adenylate cyclase type 10-like
nuclear transcription factor Y subunit alpha, transcript variant X23
nuclear transcription factor Y subunit alpha, transcript variant X17
nuclear transcription factor Y subunit alpha, transcript variant X14
nuclear transcription factor Y subunit alpha, transcript variant X13
nuclear transcription factor Y subunit alpha, transcript variant X9
nuclear transcription factor Y subunit alpha, transcript variant X20
nuclear transcription factor Y subunit alpha, transcript variant X12
nuclear transcription factor Y subunit alpha, transcript variant X5
nuclear transcription factor Y subunit alpha, transcript variant X4
nuclear transcription factor Y subunit alpha, transcript variant X22
nuclear transcription factor Y subunit alpha, transcript variant X21
nuclear transcription factor Y subunit alpha, transcript variant X19
nuclear transcription factor Y subunit alpha, transcript variant X11
nuclear transcription factor Y subunit alpha, transcript variant X10
nuclear transcription factor Y subunit alpha, transcript variant X1
nuclear transcription factor Y subunit alpha, transcript variant X15
nuclear transcription factor Y subunit alpha, transcript variant X7
nuclear transcription factor Y subunit alpha, transcript variant X3
nuclear transcription factor Y subunit alpha, transcript variant X18
nuclear transcription factor Y subunit alpha, transcript variant X16
nuclear transcription factor Y subunit alpha, transcript variant X6
nuclear transcription factor Y subunit alpha, transcript variant X2
nuclear transcription factor Y subunit alpha, transcript variant X8
nuclear transcription factor Y subunit alpha isoform X15
nuclear transcription factor Y subunit alpha isoform X10
nuclear transcription factor Y subunit alpha isoform X9
nuclear transcription factor Y subunit alpha isoform X8
nuclear transcription factor Y subunit alpha isoform X4
nuclear transcription factor Y subunit alpha isoform X12
nuclear transcription factor Y subunit alpha isoform X7
nuclear transcription factor Y subunit alpha isoform X3
nuclear transcription factor Y subunit alpha isoform X2
nuclear transcription factor Y subunit alpha isoform X14
nuclear transcription factor Y subunit alpha isoform X13
nuclear transcription factor Y subunit alpha isoform X11
nuclear transcription factor Y subunit alpha isoform X6
nuclear transcription factor Y subunit alpha isoform X5
nuclear transcription factor Y subunit alpha isoform X1
O-acyl-ADP-ribose deacylase 1, transcript variant X2
O-acyl-ADP-ribose deacylase 1, transcript variant X1
O-acyl-ADP-ribose deacylase 1, transcript variant X4
O-acyl-ADP-ribose deacylase 1, transcript variant X3
apolipoprotein B mRNA editing enzyme catalytic subunit 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 82% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 3 bases in 3 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: C->U-editing enzyme APOBEC-2
unc-5 family C-terminal like, transcript variant X6
unc-5 family C-terminal like, transcript variant X5
unc-5 family C-terminal like, transcript variant X9
unc-5 family C-terminal like, transcript variant X10
unc-5 family C-terminal like, transcript variant X1
unc-5 family C-terminal like, transcript variant X3
unc-5 family C-terminal like, transcript variant X13
unc-5 family C-terminal like, transcript variant X2
unc-5 family C-terminal like, transcript variant X4
unc-5 family C-terminal like, transcript variant X7
unc-5 family C-terminal like, transcript variant X8
unc-5 family C-terminal like, transcript variant X14
unc-5 family C-terminal like, transcript variant X16
unc-5 family C-terminal like, transcript variant X15
unc-5 family C-terminal like, transcript variant X11
unc-5 family C-terminal like, transcript variant X12
unc-5 family C-terminal like, transcript variant X17
BCL2 antagonist/killer 1, transcript variant X1
BCL2 antagonist/killer 1, transcript variant X2
bcl-2 homologous antagonist/killer isoform X2
bcl-2 homologous antagonist/killer isoform X1
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X5
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X4
inositol 1,4,5-trisphosphate receptor type 3 isoform X4
inositol 1,4,5-trisphosphate receptor type 3 isoform X5
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X1
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X2
inositol 1,4,5-trisphosphate receptor type 3, transcript variant X3
inositol 1,4,5-trisphosphate receptor type 3 isoform X1
inositol 1,4,5-trisphosphate receptor type 3 isoform X2
inositol 1,4,5-trisphosphate receptor type 3 isoform X3
ubiquinol-cytochrome-c reductase complex assembly factor 2, transcript variant X2
ubiquinol-cytochrome-c reductase complex assembly factor 2 isoform X2
ubiquinol-cytochrome-c reductase complex assembly factor 2, transcript variant X1
ubiquinol-cytochrome-c reductase complex assembly factor 2 isoform X1
inositol hexakisphosphate kinase 3, transcript variant X1
inositol hexakisphosphate kinase 3, transcript variant X2
inositol hexakisphosphate kinase 3, transcript variant X3
inositol hexakisphosphate kinase 3, transcript variant X4
inositol hexakisphosphate kinase 3, transcript variant X5
inositol hexakisphosphate kinase 3 isoform X1
inositol hexakisphosphate kinase 3 isoform X2
LEM domain nuclear envelope protein 2, transcript variant X1
LEM domain nuclear envelope protein 2, transcript variant X2
LEM domain nuclear envelope protein 2, transcript variant X6
LEM domain nuclear envelope protein 2, transcript variant X4
LEM domain nuclear envelope protein 2, transcript variant X3
LEM domain nuclear envelope protein 2, transcript variant X5
LEM domain nuclear envelope protein 2, transcript variant X7
LEM domain-containing protein 2 isoform X6
LEM domain-containing protein 2 isoform X5
LEM domain-containing protein 2 isoform X4
LEM domain-containing protein 2 isoform X3
LEM domain-containing protein 2 isoform X2
LEM domain-containing protein 2 isoform X1
LEM domain-containing protein 2 isoform X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 492 Proteins, and 25% coverage of the annotated genomic feature by RNAseq alignments
glutamate metabotropic receptor 4, transcript variant X1
glutamate metabotropic receptor 4, transcript variant X5
glutamate metabotropic receptor 4, transcript variant X2
glutamate metabotropic receptor 4, transcript variant X4
glutamate metabotropic receptor 4, transcript variant X3
glutamate metabotropic receptor 4, transcript variant X6
metabotropic glutamate receptor 4 isoform X2
metabotropic glutamate receptor 4 isoform X3
metabotropic glutamate receptor 4 isoform X1
metabotropic glutamate receptor 4 isoform X4
uncharacterized LOC119846404, transcript variant X2
uncharacterized LOC119846404, transcript variant X1
high mobility group AT-hook 1, transcript variant X2
high mobility group AT-hook 1, transcript variant X7
high mobility group AT-hook 1, transcript variant X1
high mobility group AT-hook 1, transcript variant X6
high mobility group AT-hook 1, transcript variant X5
high mobility group AT-hook 1, transcript variant X8
high mobility group AT-hook 1, transcript variant X9
high mobility group AT-hook 1, transcript variant X4
high mobility group AT-hook 1, transcript variant X3
high mobility group protein HMG-I/HMG-Y isoform X1
high mobility group protein HMG-I/HMG-Y isoform X2
high mobility group protein HMG-I/HMG-Y isoform X3
small integral membrane protein 29, transcript variant X1
small integral membrane protein 29, transcript variant X6
small integral membrane protein 29, transcript variant X14
small integral membrane protein 29, transcript variant X7
small integral membrane protein 29, transcript variant X11
small integral membrane protein 29, transcript variant X4
small integral membrane protein 29, transcript variant X3
small integral membrane protein 29, transcript variant X10
small integral membrane protein 29, transcript variant X12
small integral membrane protein 29, transcript variant X13
small integral membrane protein 29, transcript variant X9
small integral membrane protein 29, transcript variant X5
small integral membrane protein 29, transcript variant X8
small integral membrane protein 29, transcript variant X2
small integral membrane protein 29 isoform X2
small integral membrane protein 29 isoform X4
small integral membrane protein 29 isoform X3
small integral membrane protein 29 isoform X1
suppressor of cytokine signaling 2-like, transcript variant X1
suppressor of cytokine signaling 2-like, transcript variant X2
nudix hydrolase 3, transcript variant X1
nudix hydrolase 3, transcript variant X3
nudix hydrolase 3, transcript variant X2
diphosphoinositol polyphosphate phosphohydrolase 1 isoform X1
diphosphoinositol polyphosphate phosphohydrolase 1 isoform X3
diphosphoinositol polyphosphate phosphohydrolase 1 isoform X2
protein kinase C and casein kinase substrate in neurons 1, transcript variant X1
protein kinase C and casein kinase substrate in neurons 1, transcript variant X2
protein kinase C and casein kinase substrate in neurons protein 1
SAM pointed domain containing ETS transcription factor
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
SAM pointed domain-containing Ets transcription factor
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X1
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X7
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X3
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X2
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X4
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X6
inflammation and lipid regulator with UBA-like and NBR1-like domains, transcript variant X5
small nuclear ribonucleoprotein polypeptide C
UHRF1 binding protein 1, transcript variant X1
UHRF1 binding protein 1, transcript variant X3
UHRF1 binding protein 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
UHRF1 binding protein 1, transcript variant X2
TATA-box binding protein associated factor 11, transcript variant X2
TATA-box binding protein associated factor 11, transcript variant X1
transcription initiation factor TFIID subunit 11 isoform X2
transcription initiation factor TFIID subunit 11 isoform X1
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X1
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X6
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X7
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X2
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X8
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X3
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X4
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X5
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X15
ankyrin repeat and SAM domain-containing protein 1A isoform X2
ankyrin repeat and SAM domain-containing protein 1A isoform X5
ankyrin repeat and SAM domain-containing protein 1A isoform X7
ankyrin repeat and SAM domain-containing protein 1A isoform X1
ankyrin repeat and SAM domain-containing protein 1A isoform X4
ankyrin repeat and SAM domain-containing protein 1A isoform X6
ankyrin repeat and SAM domain-containing protein 1A isoform X8
ankyrin repeat and SAM domain-containing protein 1A isoform X3
ankyrin repeat and SAM domain-containing protein 1A isoform X14
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X9
ankyrin repeat and SAM domain-containing protein 1A isoform X9
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X12
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X13
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X11
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X10
ankyrin repeat and sterile alpha motif domain containing 1A, transcript variant X14
ankyrin repeat and SAM domain-containing protein 1A isoform X11
ankyrin repeat and SAM domain-containing protein 1A isoform X10
ankyrin repeat and SAM domain-containing protein 1A isoform X13
ankyrin repeat and SAM domain-containing protein 1A isoform X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
signal peptide, CUB domain and EGF like domain containing 3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 4 bases in 3 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 5 bases in 4 codons; deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: signal peptide, CUB and EGF-like domain-containing protein 3
zinc finger protein 76, transcript variant X1
zinc finger protein 76, transcript variant X2
differentially expressed in FDCP 6 homolog
peroxisome proliferator activated receptor delta, transcript variant X1
peroxisome proliferator activated receptor delta, transcript variant X2
peroxisome proliferator activated receptor delta, transcript variant X3
peroxisome proliferator activated receptor delta, transcript variant X5
peroxisome proliferator activated receptor delta, transcript variant X4
peroxisome proliferator-activated receptor delta
probable E3 ubiquitin-protein ligase makorin-1, transcript variant X1
probable E3 ubiquitin-protein ligase makorin-1 isoform X1
probable E3 ubiquitin-protein ligase makorin-1, transcript variant X2
probable E3 ubiquitin-protein ligase makorin-1 isoform X2
FA complementation group E, transcript variant X3
FA complementation group E, transcript variant X1
FA complementation group E, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 56 samples with support for all annotated introns
FA complementation group E, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
FA complementation group E, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
Fanconi anemia group E protein isoform X1
Fanconi anemia group E protein isoform X2
Fanconi anemia group E protein isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X5
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X2
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X15
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
inositol 1,4,5-triphosphate receptor associated 2-like, transcript variant X14
inositol 1,4,5-triphosphate receptor associated 2-like isoform X1
inositol 1,4,5-triphosphate receptor associated 2-like isoform X2
inositol 1,4,5-triphosphate receptor associated 1-like isoform X3
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X6
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X2
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X3
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X1
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X5
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X9
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X7
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X8
microtubule associated monooxygenase, calponin and LIM domain containing 1, transcript variant X4
sphingomyelin phosphodiesterase 2, transcript variant X2
sphingomyelin phosphodiesterase 2, transcript variant X1
TEA domain transcription factor 3, transcript variant X1
TEA domain transcription factor 3, transcript variant X2
TEA domain transcription factor 3, transcript variant X3
transcriptional enhancer factor TEF-5 isoform X2
transcriptional enhancer factor TEF-5 isoform X3
transcriptional enhancer factor TEF-5 isoform X1
TUB like protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
TUB like protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
FKBP prolyl isomerase 5, transcript variant X13
FKBP prolyl isomerase 5, transcript variant X14
FKBP prolyl isomerase 5, transcript variant X17
FKBP prolyl isomerase 5, transcript variant X8
FKBP prolyl isomerase 5, transcript variant X2
FKBP prolyl isomerase 5, transcript variant X1
FKBP prolyl isomerase 5, transcript variant X3
FKBP prolyl isomerase 5, transcript variant X19
FKBP prolyl isomerase 5, transcript variant X10
FKBP prolyl isomerase 5, transcript variant X16
FKBP prolyl isomerase 5, transcript variant X5
FKBP prolyl isomerase 5, transcript variant X11
FKBP prolyl isomerase 5, transcript variant X15
FKBP prolyl isomerase 5, transcript variant X6
FKBP prolyl isomerase 5, transcript variant X4
FKBP prolyl isomerase 5, transcript variant X9
FKBP prolyl isomerase 5, transcript variant X12
FKBP prolyl isomerase 5, transcript variant X7
FKBP prolyl isomerase 5, transcript variant X18
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X1
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X5
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X4
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X3
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X2
peptidyl-prolyl cis-trans isomerase FKBP5 isoform X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
LHFPL tetraspan subfamily member 5 protein
SRSF protein kinase 1, transcript variant X1
SRSF protein kinase 1, transcript variant X3
SRSF protein kinase 1, transcript variant X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: testis anion transporter 1
mitogen-activated protein kinase 14, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
mitogen-activated protein kinase 14, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
mitogen-activated protein kinase 14, transcript variant X1
mitogen-activated protein kinase 14, transcript variant X2
mitogen-activated protein kinase 14, transcript variant X4
mitogen-activated protein kinase 14, transcript variant X3
mitogen-activated protein kinase 14 isoform X3
mitogen-activated protein kinase 14 isoform X4
mitogen-activated protein kinase 14 isoform X1
mitogen-activated protein kinase 14 isoform X2
mitogen-activated protein kinase 14 isoform X7
mitogen-activated protein kinase 14 isoform X5
mitogen-activated protein kinase 14, transcript variant X6
mitogen-activated protein kinase 14 isoform X6
mitogen-activated protein kinase 13, transcript variant X1
mitogen-activated protein kinase 13 isoform X1
mitogen-activated protein kinase 13, transcript variant X2
mitogen-activated protein kinase 13 isoform X2
bromodomain and PHD finger containing 3, transcript variant X1
bromodomain and PHD finger containing 3, transcript variant X3
bromodomain and PHD finger containing 3, transcript variant X4
bromodomain and PHD finger containing 3, transcript variant X2
bromodomain and PHD finger-containing protein 3 isoform X1
bromodomain and PHD finger-containing protein 3 isoform X2
bromodomain and PHD finger-containing protein 3 isoform X3
bromodomain and PHD finger-containing protein 3 isoform X4
chemokine-like protein TAFA-5, transcript variant X3
chemokine-like protein TAFA-5, transcript variant X2
chemokine-like protein TAFA-5 isoform X3
chemokine-like protein TAFA-5 isoform X2
chemokine-like protein TAFA-5, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
chemokine-like protein TAFA-5 isoform X1
uncharacterized LOC119846242, transcript variant X1
uncharacterized LOC119846242, transcript variant X2
TBC1 domain family member 22B, transcript variant X2
TBC1 domain family member 22B, transcript variant X1
TBC1 domain family member 22B isoform X2
TBC1 domain family member 22B isoform X1
TBC1 domain family member 22B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
TBC1 domain family member 22B isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 11 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Pim-1 proto-oncogene, serine/threonine kinase
protein phosphatase 1 regulatory subunit 14A-like, transcript variant X2
protein phosphatase 1 regulatory subunit 14A-like, transcript variant X1
protein phosphatase 1 regulatory subunit 14A-like isoform X1
protein phosphatase 1 regulatory subunit 14A-like isoform X2
FYVE, RhoGEF and PH domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 long SRA reads, 17 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
FYVE, RhoGEF and PH domain-containing protein 2 isoform X1
FYVE, RhoGEF and PH domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
FYVE, RhoGEF and PH domain-containing protein 2 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 87% coverage of the annotated genomic feature by RNAseq alignments
chromosome 21 C6orf89 homolog, transcript variant X2
chromosome 21 C6orf89 homolog, transcript variant X6
chromosome 21 C6orf89 homolog, transcript variant X3
chromosome 21 C6orf89 homolog, transcript variant X4
chromosome 21 C6orf89 homolog, transcript variant X1
chromosome 21 C6orf89 homolog, transcript variant X5
bombesin receptor-activated protein C6orf89 homolog isoform X2
bombesin receptor-activated protein C6orf89 homolog isoform X1
bombesin receptor-activated protein C6orf89 homolog isoform X3
RAB44, member RAS oncogene family, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 long SRA reads, 2 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
RAB44, member RAS oncogene family, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 26 samples with support for all annotated introns
RAB44, member RAS oncogene family, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
cyclin dependent kinase inhibitor 1A, transcript variant X2
cyclin dependent kinase inhibitor 1A, transcript variant X1
cyclin dependent kinase inhibitor 1A, transcript variant X3
cyclin-dependent kinase inhibitor 1 isoform X2
cyclin-dependent kinase inhibitor 1 isoform X1
cyclin-dependent kinase inhibitor 1 isoform X3
serine and arginine rich splicing factor 3
serine/threonine kinase 38, transcript variant X1
serine/threonine-protein kinase 38 isoform X1
serine/threonine kinase 38, transcript variant X2
serine/threonine-protein kinase 38 isoform X2
potassium channel tetramerization domain containing 20, transcript variant X1
potassium channel tetramerization domain containing 20, transcript variant X2
potassium channel tetramerization domain containing 20, transcript variant X4
potassium channel tetramerization domain containing 20, transcript variant X3
potassium channel tetramerization domain containing 20, transcript variant X5
BTB/POZ domain-containing protein KCTD20 isoform X1
BTB/POZ domain-containing protein KCTD20 isoform X2
BTB/POZ domain-containing protein KCTD20 isoform X3
ETS variant transcription factor 7, transcript variant X1
ETS variant transcription factor 7, transcript variant X3
ETS variant transcription factor 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 80% coverage of the annotated genomic feature by RNAseq alignments
potassium voltage-gated channel subfamily A member 3-like, transcript variant X1
potassium voltage-gated channel subfamily A member 3-like, transcript variant X2
potassium voltage-gated channel subfamily A member 3-like
potassium voltage-gated channel subfamily A member 2, transcript variant X1
potassium voltage-gated channel subfamily A member 2, transcript variant X2
potassium voltage-gated channel subfamily A member 2
potassium voltage-gated channel subfamily A member 10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 50 Proteins, and 71% coverage of the annotated genomic feature by RNAseq alignments
adhesion G protein-coupled receptor E2-like
LOW QUALITY PROTEIN: adhesion G protein-coupled receptor E2-like
late endosomal/lysosomal adaptor, MAPK and MTOR activator 5
uncharacterized LOC119846266, transcript variant X2
uncharacterized LOC119846266, transcript variant X1
LOW QUALITY PROTEIN: monocarboxylate transporter 5
potassium voltage-gated channel subfamily C member 4, transcript variant X2
potassium voltage-gated channel subfamily C member 4, transcript variant X1
potassium voltage-gated channel subfamily C member 4, transcript variant X3
potassium voltage-gated channel subfamily C member 4
solute carrier family 6 member 17, transcript variant X3
solute carrier family 6 member 17, transcript variant X2
solute carrier family 6 member 17, transcript variant X1
sodium-dependent neutral amino acid transporter SLC6A17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 40% coverage of the annotated genomic feature by RNAseq alignments
striatin interacting protein 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 124 long SRA reads, 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
striatin interacting protein 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 long SRA reads, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
striatin-interacting protein 1 isoform X1
striatin-interacting protein 1 isoform X2
adenosylhomocysteinase like 1, transcript variant X1
adenosylhomocysteinase like 1, transcript variant X3
S-adenosylhomocysteine hydrolase-like protein 1 isoform X1
S-adenosylhomocysteine hydrolase-like protein 1 isoform X3
adenosylhomocysteinase like 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 38 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 70 samples with support for all annotated introns
S-adenosylhomocysteine hydrolase-like protein 1 isoform X2
colony stimulating factor 1, transcript variant X2
colony stimulating factor 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 6 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
colony stimulating factor 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
macrophage colony-stimulating factor 1 isoform X2
macrophage colony-stimulating factor 1 isoform X3
macrophage colony-stimulating factor 1 isoform X1
kinesin family member 21B, transcript variant X6
kinesin family member 21B, transcript variant X4
kinesin family member 21B, transcript variant X2
kinesin family member 21B, transcript variant X1
kinesin family member 21B, transcript variant X5
kinesin family member 21B, transcript variant X3
calcium voltage-gated channel subunit alpha1 S, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 long SRA reads, 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 16 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
calcium voltage-gated channel subunit alpha1 S, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
voltage-dependent L-type calcium channel subunit alpha-1S isoform X3
voltage-dependent L-type calcium channel subunit alpha-1S isoform X2
voltage-dependent L-type calcium channel subunit alpha-1S isoform X1
voltage-dependent L-type calcium channel subunit alpha-1S isoform X4
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X3
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X2
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like, transcript variant X1
alpha-1,6-mannosyl-glycoprotein 4-beta-N-acetylglucosaminyltransferase-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
PTPRF interacting protein alpha 4, transcript variant X1
PTPRF interacting protein alpha 4, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 long SRA reads, and 99% coverage of the annotated genomic feature by RNAseq alignments
PTPRF interacting protein alpha 4, transcript variant X2
PTPRF interacting protein alpha 4, transcript variant X3
PTPRF interacting protein alpha 4, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adenosine A1 receptor, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
adenosine A1 receptor, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
adenosine A1 receptor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 47 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
myosin binding protein H, transcript variant X1
myosin binding protein H, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
choline/ethanolamine phosphotransferase 1, transcript variant X1
choline/ethanolamine phosphotransferase 1, transcript variant X4
choline/ethanolamine phosphotransferase 1, transcript variant X3
choline/ethanolamine phosphotransferase 1, transcript variant X2
choline/ethanolamine phosphotransferase 1, transcript variant X5
choline/ethanolaminephosphotransferase 1
choline/ethanolamine phosphotransferase 1, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
DNA damage regulated autophagy modulator 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
DNA damage regulated autophagy modulator 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 long SRA reads, 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 66 samples with support for all annotated introns
DNA damage regulated autophagy modulator 2, transcript variant X3
DNA damage-regulated autophagy modulator protein 2 isoform X1
DNA damage-regulated autophagy modulator protein 2 isoform X2
ligand dependent nuclear receptor interacting factor 1, transcript variant X1
ligand dependent nuclear receptor interacting factor 1, transcript variant X2
ligand-dependent nuclear receptor-interacting factor 1 isoform X1
ligand-dependent nuclear receptor-interacting factor 1 isoform X2
cryptochrome-1-like, transcript variant X1
cryptochrome-1-like, transcript variant X3
cryptochrome-1-like, transcript variant X2
ubiquitin conjugating enzyme E2 T, transcript variant X2
ubiquitin conjugating enzyme E2 T, transcript variant X1
leucine rich repeat containing G protein-coupled receptor 6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 long SRA reads, 15 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine-rich repeat-containing G-protein coupled receptor 6
receptor-type tyrosine-protein phosphatase V-like, transcript variant X2
receptor-type tyrosine-protein phosphatase V-like, transcript variant X1
receptor-type tyrosine-protein phosphatase V-like isoform X2
receptor-type tyrosine-protein phosphatase V-like isoform X1
receptor-type tyrosine-protein phosphatase V-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
protein tyrosine phosphatase non-receptor type 7
tyrosine-protein phosphatase non-receptor type 7
E74 like ETS transcription factor 3, transcript variant X3
E74 like ETS transcription factor 3, transcript variant X2
E74 like ETS transcription factor 3, transcript variant X1
ETS-related transcription factor Elf-3 isoform X2
ETS-related transcription factor Elf-3 isoform X1
protein phosphatase 1 regulatory subunit 12B, transcript variant X4
protein phosphatase 1 regulatory subunit 12B, transcript variant X3
protein phosphatase 1 regulatory subunit 12B, transcript variant X2
protein phosphatase 1 regulatory subunit 12B, transcript variant X1
protein phosphatase 1 regulatory subunit 12B, transcript variant X6
protein phosphatase 1 regulatory subunit 12B, transcript variant X10
protein phosphatase 1 regulatory subunit 12B, transcript variant X8
protein phosphatase 1 regulatory subunit 12B, transcript variant X9
protein phosphatase 1 regulatory subunit 12B isoform X4
protein phosphatase 1 regulatory subunit 12B isoform X3
protein phosphatase 1 regulatory subunit 12B isoform X2
protein phosphatase 1 regulatory subunit 12B isoform X1
protein phosphatase 1 regulatory subunit 12B isoform X6
protein phosphatase 1 regulatory subunit 12B isoform X8
protein phosphatase 1 regulatory subunit 12B isoform X9
protein phosphatase 1 regulatory subunit 12B, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
protein phosphatase 1 regulatory subunit 12B isoform X5
protein phosphatase 1 regulatory subunit 12B, transcript variant X7
protein phosphatase 1 regulatory subunit 12B isoform X7
cysteine and glycine rich protein 1, transcript variant X1
cysteine and glycine rich protein 1, transcript variant X2
pleckstrin homology like domain family A member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, 10 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
pleckstrin homology-like domain family A member 3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 20 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: troponin I, slow skeletal muscle
troponin T2, cardiac type, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 37 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
troponin T2, cardiac type, transcript variant X3
troponin T2, cardiac type, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 42 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
troponin T2, cardiac type, transcript variant X1
troponin T2, cardiac type, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 55 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
troponin T2, cardiac type, transcript variant X5
uncharacterized LOC119846475, transcript variant X3
uncharacterized LOC119846475, transcript variant X1
uncharacterized LOC119846475, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 8 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
immunoglobulin-like and fibronectin type III domain-containing protein 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 37% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: immunoglobulin-like and fibronectin type III domain-containing protein 1
transmembrane protein 9, transcript variant X2
transmembrane protein 9, transcript variant X1
transmembrane protein 9, transcript variant X3
proton-transporting V-type ATPase complex assembly regulator TMEM9
epidermal growth factor receptor kinase substrate 8-like protein 3 isoform X1
epidermal growth factor receptor kinase substrate 8-like protein 3 isoform X2
innate immunity activator, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
innate immunity activator, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
innate immunity activator, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
innate immunity activator protein isoform X2
innate immunity activator protein isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 52% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable G-protein coupled receptor 25
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01268
endosome-lysosome associated apoptosis and autophagy regulator 1, transcript variant X2
endosome-lysosome associated apoptosis and autophagy regulator 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
endosome-lysosome associated apoptosis and autophagy regulator 1, transcript variant X1
endosome/lysosome-associated apoptosis and autophagy regulator 1 isoform X1
endosome/lysosome-associated apoptosis and autophagy regulator 1 isoform X3
endosome/lysosome-associated apoptosis and autophagy regulator 1 isoform X2
small nucleolar RNA SNORA16B/SNORA16A family
COORDINATES: nucleotide motif:Rfam:12.0:RF00190
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X1
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X2
cadherin EGF LAG seven-pass G-type receptor 2 isoform X1
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X5
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X6
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X3
cadherin EGF LAG seven-pass G-type receptor 2, transcript variant X4
cadherin EGF LAG seven-pass G-type receptor 2 isoform X2
cadherin EGF LAG seven-pass G-type receptor 2 isoform X3
proline/serine-rich coiled-coil protein 1
peptidyl-prolyl cis-trans isomerase-like 1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
synaptophysin like 2, transcript variant X2
synaptophysin like 2, transcript variant X1
probable transmembrane reductase CYB561D1, transcript variant X1
probable transmembrane reductase CYB561D1 isoform X1
probable transmembrane reductase CYB561D1, transcript variant X2
probable transmembrane reductase CYB561D1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 long SRA reads, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
G protein-coupled receptor 61, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, 14 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
G protein-coupled receptor 61, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
guanine nucleotide-binding protein G(i) subunit alpha-3
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 59 Proteins, and 66% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; substituted 2 bases at 2 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: guanine nucleotide-binding protein G(t) subunit alpha-2
adenosine monophosphate deaminase 2, transcript variant X1
adenosine monophosphate deaminase 2, transcript variant X2
adenosine monophosphate deaminase 2, transcript variant X3
adenosine monophosphate deaminase 2, transcript variant X4
LOW QUALITY PROTEIN: adiponectin receptor protein 1
translocase of inner mitochondrial membrane 17A, transcript variant X2
translocase of inner mitochondrial membrane 17A, transcript variant X1
mitochondrial import inner membrane translocase subunit Tim17-A isoform X2
mitochondrial import inner membrane translocase subunit Tim17-A isoform X1
myb-related transcription factor, partner of profilin-like
RAB interacting factor, transcript variant X2
guanine nucleotide exchange factor MSS4 isoform X2
RAB interacting factor, transcript variant X1
guanine nucleotide exchange factor MSS4 isoform X1
tubulin alpha-8 chain, transcript variant X1
tubulin alpha-8 chain, transcript variant X2
tubulin alpha-8 chain, transcript variant X3
lysine demethylase 5B, transcript variant X1
lysine demethylase 5B, transcript variant X9
lysine demethylase 5B, transcript variant X7
lysine demethylase 5B, transcript variant X6
lysine demethylase 5B, transcript variant X5
lysine demethylase 5B, transcript variant X3
lysine demethylase 5B, transcript variant X8
lysine demethylase 5B, transcript variant X2
lysine demethylase 5B, transcript variant X4
lysine-specific demethylase 5B isoform X1
lysine-specific demethylase 5B isoform X7
lysine-specific demethylase 5B isoform X6
lysine-specific demethylase 5B isoform X5
lysine-specific demethylase 5B isoform X3
lysine-specific demethylase 5B isoform X2
lysine-specific demethylase 5B isoform X4
lysine-specific demethylase 5B isoform X9
lysine-specific demethylase 5B isoform X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 long SRA read, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 50 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 53 samples with support for all annotated introns
leucine zipper like transcription regulator 1, transcript variant X10
leucine zipper like transcription regulator 1, transcript variant X9
leucine zipper like transcription regulator 1, transcript variant X6
leucine zipper like transcription regulator 1, transcript variant X13
leucine zipper like transcription regulator 1, transcript variant X2
leucine zipper like transcription regulator 1, transcript variant X3
leucine zipper like transcription regulator 1, transcript variant X8
leucine zipper like transcription regulator 1, transcript variant X4
leucine zipper like transcription regulator 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine zipper like transcription regulator 1, transcript variant X5
leucine zipper like transcription regulator 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
leucine zipper like transcription regulator 1, transcript variant X1
leucine zipper like transcription regulator 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 long SRA reads, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
leucine-zipper-like transcriptional regulator 1 isoform X3
leucine-zipper-like transcriptional regulator 1 isoform X2
leucine-zipper-like transcriptional regulator 1 isoform X1
leucine-zipper-like transcriptional regulator 1 isoform X4
leucine-zipper-like transcriptional regulator 1 isoform X5
leucine-zipper-like transcriptional regulator 1 isoform X8
leucine-zipper-like transcriptional regulator 1 isoform X9
leucine-zipper-like transcriptional regulator 1 isoform X11
leucine-zipper-like transcriptional regulator 1 isoform X6
leucine-zipper-like transcriptional regulator 1 isoform X7
leucine-zipper-like transcriptional regulator 1 isoform X10
sperm acrosome membrane-associated protein 3-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 86% coverage of the annotated genomic feature by RNAseq alignments